Ensayos clínicos

8.676 ensayos encontrados

ReclutandoClinicalTrials.gov

Incidence of Complications From the Alveolar Opening Maneuver in Mechanically Ventilated Children With Respiratory Distress Syndrome

OBSERVATIONALInicio: 18 de ago de 2025ID: NCT07233304

ReclutandoClinicalTrials.gov

The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling

OBSERVATIONALInicio: 20 de dic de 2025ID: NCT06717295

ReclutandoFase 3ClinicalTrials.gov

A Phase 3 Open-label, Randomized, Active-controlled, Multicenter Trial to Evaluate the Efficacy and Safety of Orally Administered BAY 2927088 Compared With Standard of Care as a First-line Therapy in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With HER2-activating Mutations

INTERVENTIONALInicio: 28 de ago de 2024ID: NCT06452277

ReclutandoFase 3ClinicalTrials.gov

A Phase 3, Multicenter, Open-Label, Randomized Trial to Compare the Efficacy and Safety of Elritercept Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes in ESA-naïve Adult Participants Who Require Red Blood Cell Transfusions

INTERVENTIONALInicio: 1 de abr de 2026ID: NCT07422480

ReclutandoFase 3ClinicalTrials.gov

A Randomized, Open-label, Parallel-group, Non-inferiority Study Comparing Efficacy, Safety, and Tolerability of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis, Followed by Open-label Treatment With Remibrutinib

INTERVENTIONALInicio: 23 de jul de 2025ID: NCT06846281

ReclutandoFase 2ClinicalTrials.gov

Cardiovascular Effects of SGLT2 Inhibitors in Hemodialysis Patients: A Phase 2 Randomized Study

INTERVENTIONALInicio: 1 de may de 2025ID: NCT06929169

ReclutandoFase 1ClinicalTrials.gov

A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986326 in Adult Participants With Discoid Lupus Erythematosus, Subacute Cutaneous Lupus Erythematosus, or Systemic Lupus Erythematosus

INTERVENTIONALInicio: 21 de sept de 2023ID: NCT06013995

ReclutandoFase 3ClinicalTrials.gov

A Randomized Phase 2/3 Study of BMS-986504 in Combination With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

INTERVENTIONALInicio: 2 de ene de 2026ID: NCT07063745

ReclutandoFase 2ClinicalTrials.gov

A Phase 2, Open-label, Basket Study Investigating the Safety and Efficacy of GTX-102 in Adult and Pediatric Subjects With Deletion- or Nondeletion-type Angelman Syndrome

INTERVENTIONALInicio: 13 de oct de 2025ID: NCT07157254

ReclutandoFase 3ClinicalTrials.gov

An Open-label, Randomized, Phase 3 Study to Evaluate Patritumab Deruxtecan Monotherapy Versus Treatment of Physician's Choice in Hormone Receptor-positive, HER2-negative Unresectable Locally Advanced or Metastatic Breast Cancer (HERTHENA-Breast04)

INTERVENTIONALInicio: 21 de jul de 2025ID: NCT07060807

ReclutandoClinicalTrials.gov

Pulmonary Hypertension Institutional Registry at Hospital Italiano de Buenos Aires

OBSERVATIONALInicio: 1 de ene de 2017ID: NCT01501838

ReclutandoClinicalTrials.gov

Effectiveness of Carotid Sinus Massage in Modified Trendelenburg Position for Acute Headache Episodes: A Pilot Study

INTERVENTIONALInicio: 21 de dic de 2024ID: NCT06745648

ReclutandoFase 3ClinicalTrials.gov

A Phase 3 Multicenter, Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lutikizumab in Adult and Adolescent Subjects With Moderate to Severe Hidradenitis Suppurativa

INTERVENTIONALInicio: 27 de jun de 2024ID: NCT06468228

ReclutandoClinicalTrials.gov

A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain

OBSERVATIONALInicio: 19 de nov de 2012ID: NCT01719055

ReclutandoClinicalTrials.gov

Evaluation of Functional Recovery of Facial Paralysis in People With Different Kinesic Treatment Options.

INTERVENTIONALInicio: 1 de jun de 2023ID: NCT06532903

ReclutandoFase 3ClinicalTrials.gov

A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Once Daily in Participants With Hypertension and Obesity or Overweight: Randomized, Double-Blind, Placebo-Controlled Trials (ATTAIN-HYPERTENSION)

INTERVENTIONALInicio: 30 de abr de 2025ID: NCT06948435

ReclutandoFase 3ClinicalTrials.gov

A Multicenter, Parallel-group, Double-blind, 2-Arm, Phase III Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

INTERVENTIONALInicio: 20 de jun de 2024ID: NCT06455449

ReclutandoFase 3ClinicalTrials.gov

A Phase 3 Randomized, Open-Label Study of OP-1250 Monotherapy vs Standard of Care for the Treatment of ER+, HER2- Advanced or Metastatic Breast Cancer Following Endocrine and CDK 4/6 Inhibitor Therapy (OPERA-01)

INTERVENTIONALInicio: 16 de nov de 2023ID: NCT06016738

ReclutandoFase 2ClinicalTrials.gov

A Phase 2, Randomized, Open-Label, Comparator-Controlled Trial to Evaluate the Efficacy and Safety of LY3938577 in Study Participants, With Type 2 Diabetes Previously Treated With Basal Insulin

INTERVENTIONALInicio: 13 de oct de 2025ID: NCT07215312

ReclutandoFase 3ClinicalTrials.gov

A Phase III Study to Evaluate the Efficacy of INM004 (Shiga Antitoxin) in Pediatric Patients With Shiga Toxin-producing Escherichia Coli-associated Hemolytic Uremic Syndrome.

INTERVENTIONALInicio: 5 de oct de 2024ID: NCT06389474